MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-64-0003194
Arosol Pharmaceuticals Private Limited - pharma in Saharanpur, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹16.88 Cr
▼ 2% YoY
Net profit · FY 2023
₹21.51 Lakh
Net margin 1.3%
EBITDA · FY 2023
₹57.5 Lakh
EBITDA margin 3.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹80 Lakh
Issued & subscribed
Open charges
₹8.79 Cr
Satisfied ₹1.78 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
81
Provident fund records
About Arosol Pharmaceuticals Private Limited
Data last updated:
Arosol Pharmaceuticals Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 11 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24211UP2007PTC033144. Its GSTIN is 09AAGCA2848D1ZS (Uttar Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹80 Lakh. It is led by directors including Nidhi Arora and Krishan Lal Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gali No.1 Link Road Jwala Nagar, Saharanpur, Uttar Pradesh, India – 247001.
As per the financials filed for FY 2023, the company reported a revenue of ₹16.88 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹21.51 Lakh (net margin 1.3%) and EBITDA of ₹57.5 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
The company has about 81 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹8.79 Cr and satisfied charges of ₹1.78 Cr on record.
Arosol Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-64-0003194). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arosolpharma.com.
Company details
CIN U24211UP2007PTC033144
Registration Number 033144
Incorporation Date 11 April 2007
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-64-0003194
Recognitions & Rankings of Arosol Pharmaceuticals
Contact details
Arosol Pharmaceuticals Private Limited's registered office is in Saharanpur, Uttar Pradesh. Its website is arosolpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGali No.1 Link Road Jwala Nagar, Saharanpur, Uttar Pradesh, India – 247001
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Arosol Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Arosol Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Arosol Pharmaceuticals Private Limited
FY 2025 filings availableArosol Pharmaceuticals Private Limited reported revenue of ₹16.88 Cr (down 2% YoY) for FY 2023.
Revenue · FY 2023
₹16.88 Cr ▼ 2%
Net profit · FY 2023
₹21.51 Lakh margin 1.3%
EBITDA · FY 2023
₹57.5 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 15%
3 years · compounded
▼ 18%
5 years · compounded
▼ 2%
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹16.88 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arosol Pharmaceuticals Private Limited, buy the company report.
Board of directors of Arosol Pharmaceuticals Private Limited
Arosol Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidhi Arora | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
| Krishan Lal Arora Also directs: Nutricare Life Sciences Limited | Director | 11 Apr 2007 | 19 Years 6 Months | Current |
| Shalini Arora Also directs: Ansh Polymer Private Limited | Director | 11 Apr 2007 | 19 Years 6 Months | Current |
| Anshul Arora Also directs: Nutricare Life Sciences Limited, Ansh Polymer Private Limited, Care Genie Ventures Private Limited and 1 more | Director | 11 Apr 2007 | 19 Years 6 Months | Current |
Auditor
Arosol Pharmaceuticals Private Limited is audited by MUKESH K GOEL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH K GOEL & ASSOCIATES | FY 2023 | 004078C |
Shareholding
The shareholding of Arosol Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Arosol Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.79 Cr
Satisfied charges
₹1.78 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Nov 2022 | 100679072 | Hdfc Bank Limited | ₹15 Lakh | Open | |
| 21 Mar 2013 | 10412585 | Hdfc Bank Limited | ₹8.64 Cr | Open | |
| 06 Sep 2010 | 10240705 | Punjab National Bank | ₹16.5 Lakh | Satisfied | |
| 18 Oct 2008 | 10133127 | Punjab National Bank | ₹17.6 Lakh | Satisfied | |
| 21 Nov 2007 | 10082700 | Punjab National Bank | ₹19 Lakh | Satisfied |
To see the full charge records of Arosol Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Arosol Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Arosol Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 107 overdue payments to 28 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 28)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Kantian Gram Udyog Samiti(Regd) | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Arosol Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Arosol Pharmaceuticals Private Limited has a workforce of 81 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
81
Active EPFO establishments
1
Employee growth
-10.99%
GST
Arosol Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCA2848D1ZS | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arosol Pharmaceuticals Private Limited, buy the company report.
Recent activity
Arosol Pharmaceuticals Private Limited has 6 board changes on record since 2007: 4 appointments and 2 cessations. The latest: Nidhi Arora ceased to be Additional Director on 29 Sep 2018.
AGM
Arosol Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 8.64 Cr registered on 21 Mar 2013 with Charge ID 10412585 was modified on 25 Jul 2025.
Filing
Arosol Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 100679072 was registered on 29 Nov 2022.
Ceased
Nidhi Arora ceased to be Additional Director.
Appointed
Nidhi Arora was appointed as Director.
Ceased
Vipul Arora ceased to be Director.
Charges
A charge registered on 06 Sep 2010 via Charge ID 10240705 with Punjab National Bank was fully satisfied on 02 May 2013.
Charges
A charge registered on 18 Oct 2008 via Charge ID 10133127 with Punjab National Bank was fully satisfied on 02 May 2013.
Charges
A charge registered on 21 Nov 2007 via Charge ID 10082700 with Punjab National Bank was fully satisfied on 02 May 2013.
Charges
A charge registered on 21 Nov 2007 via Charge ID 10082701 with Punjab National Bank was fully satisfied on 29 Apr 2013.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.64 Cr with Charge ID 10412585 was registered on 21 Mar 2013.
9 earlier events are in the company report.
Frequently asked questions
Arosol Pharmaceuticals is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 11 April 2007 (19+ years old) and is registered under CIN U24211UP2007PTC033144.
Arosol Pharmaceuticals has 4 current directors:
- Nidhi Arora - Director
- Krishan Lal Arora - Director
- Shalini Arora - Director
- Anshul Arora - Director
The latest financial statements of Arosol Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arosol Pharmaceuticals is 09AAGCA2848D1ZS, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Arosol Pharmaceuticals is U24211UP2007PTC033144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arosol Pharmaceuticals was incorporated on 11 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kanpur.
Nidhi Arora ceased to be Additional Director on 29 Sep 2018. Nidhi Arora was appointed as Director on 20 Feb 2018. Vipul Arora ceased to be Director on 20 Feb 2018. Arosol Pharmaceuticals has 6 board changes on record in total.
Yes, Arosol Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-64-0003194).
Arosol Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 107 overdue payments to 28 micro and small suppliers. The latest return was filed on 30 May 2019.
Arosol Pharmaceuticals can be reached through the website arosolpharma.com. Its registered office is in Saharanpur, Uttar Pradesh, India.
The registered office of Arosol Pharmaceuticals is at Gali No.1 Link Road Jwala Nagar, Saharanpur, Uttar Pradesh, India – 247001.